SRZN Surrozen, Inc. - Common Stock
SRZN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
SRZN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
SRZN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 3 27.3%
- Buy 7 63.6%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
4 analysts · 2026-08-15Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.41 | $-1.31 | 0.90% |
| March 31, 2026 | $-11.65 | $-1.11 | -10.5% |
| Dec. 31, 2025 | $-14.03 | $-1.21 | -12.8% |
| Sept. 30, 2025 | $-8.36 | $-1.16 | -7.2% |
| June 30, 2025 | $2.55 | $-1.13 | 3.7% |
| March 31, 2025 | $-7.43 | $-1.82 | -5.6% |
| Dec. 31, 2024 | $-9.10 | $-1.37 | -7.7% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SRZN | — | — | — | — | — | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| ZSQR | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| ALXO | $61M | -0.6 | — | — | -225.0% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $5M | $983.0K | |
| R&D Expense | $9M | $7M | |
| SG&A Expense | $6M | $4M | |
| Operating Expenses | $15M | $11M | |
| Operating Income | $-10M | $-10M | |
| Interest Income | $912.0K | $296.0K | |
| Other Non-op | $-41M | $38M | |
| Income Tax | $0 | $0 | |
| Net Income | $-128M | $-27M | |
| EPS (Basic) | $-11.65 | $-7.43 | |
| EPS (Diluted) | $-11.65 | $-7.43 | |
| Shares (Basic) | 10,949 | 3,628 | |
| Shares (Diluted) | 10,949 | 3,628 | |
| EBITDA | $-10M | · |
Balance Sheet 18
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $107M | · | |
| Receivables | $5M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $114M | · | |
| PP&E (Net) | $488.0K | · | |
| Other Non-current Assets | $34.0K | · | |
| Total Assets | $121M | · | |
| Accounts Payable | $889.0K | · | |
| Accrued Liabilities | $7M | · | |
| Current Liabilities | $10M | · | |
| Capital Leases | $5M | · | |
| Total Liabilities | $399M | · | |
| Common Stock | $1.0K | · | |
| Paid-in Capital | $377M | · | |
| Retained Earnings | $-655M | · | |
| Stockholders' Equity | $-278M | · | |
| Liabilities + Equity | $121M | · | |
| Shares Outstanding | 11,490,000 | · |
Cash Flow 11
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $65.0K | $294.0K | |
| Stock-based Comp | $2M | $834.0K | |
| Deferred Tax | $0 | $0 | |
| Operating Cash Flow | $-12M | $-9M | |
| CapEx | $120.0K | $27.0K | |
| Investing Cash Flow | $-120.0K | $-27.0K | |
| Stock Issued | $0 | $76M | |
| Net Stock Activity | $0 | · | |
| Financing Cash Flow | $30M | $76M | |
| Net Change in Cash | $18M | $67M | |
| Free Cash Flow | $-13M | · |
Profitability 5
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -209.1% | · | |
| Net Margin | -2550.1% | · | |
| EBITDA Margin | -209.1% | · | |
| ROA | -108.3% | · | |
| ROE | 93.6% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 11.9 | · | |
| Quick Ratio | 11.7 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 1.4 | · |
Valuation (TTM) 9
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $8M | · | |
| Net Income TTM | $-186M | · | |
| Market Cap | $335M | · | |
| P/E | -1.2 | · | |
| P/S | 42.1 | · | |
| P/B | -1.2 | · | |
| P / Cash Flow | -26.8 | · | |
| P / FCF | -26.5 | · | |
| Earnings Yield | -85.4% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 70 filers · $294.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 29 (+17 vs prior Q) | 15 (+4 vs prior Q) | 16 (+1 vs prior Q) | 11 (-2 vs prior Q) | +1.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Column Group LLC | $49,744,853 | 1,916,950 | 16.90% | Shares |
| TCG Crossover Management, LLC | $38,226,971 | 1,473,101 | 12.99% | Shares |
| Boxer Capital Management, LLC | $26,963,591 | 1,105,683 | 9.16% | Shares |
| MILLENNIUM MANAGEMENT LLC | $17,725,900 | 683,079 | 6.02% | Shares |
| Point72 Asset Management, L.P. | $17,237,858 | 664,272 | 5.86% | Shares |
| Venrock Adviser, LLC | $16,424,559 | 632,931 | 5.58% | Shares |
| PERCEPTIVE ADVISORS LLC | $13,078,411 | 503,985 | 4.44% | Shares |
| Spruce Street Capital LP | $11,211,438 | 432,040 | 3.81% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,186,673 | 392,550 | 3.46% | Shares |
| BRAIDWELL LP | $10,140,040 | 390,753 | 3.45% | Shares |
| Kalehua Capital Management LLC | $9,995,369 | 385,178 | 3.40% | Shares |
| Vestal Point Capital, LP | $7,906,161 | 304,669 | 2.69% | Shares |
| STEMPOINT CAPITAL LP | $7,087,983 | 273,140 | 2.41% | Shares |
| 5AM Venture Management, LLC | $7,038,938 | 271,250 | 2.39% | Shares |
| Vivo Capital, LLC | $6,747,000 | 260,000 | 2.29% | Shares |
| Balyasny Asset Management L.P. | $5,320,579 | 205,032 | 1.81% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $4,499,600 | 173,395 | 1.53% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,367,718 | 168,284 | 1.48% | Shares |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | $3,456,722 | 133,207 | 1.17% | Shares |
| STATE STREET CORP | $3,453,530 | 133,084 | 1.17% | Shares |
| GOLDMAN SACHS GROUP INC | $2,634,574 | 101,525 | 0.90% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2,300,545 | 88,653 | 0.78% | Shares |
| Euclidean Capital LLC | $2,275,711 | 87,696 | 0.77% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,845,538 | 71,119 | 0.63% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,545,971 | 59,575 | 0.53% | Shares |
| ArrowMark Colorado Holdings LLC | $1,430,442 | 55,123 | 0.49% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,324,125 | 51,026 | 0.45% | Shares |
| Eversept Partners, LP | $1,239,813 | 47,777 | 0.42% | Shares |
| Walleye Capital LLC | $1,007,690 | 38,832 | 0.34% | Shares |
| Ellsworth Advisors, LLC | $855,977 | 39,283 | 0.29% | Shares |
| BANK OF AMERICA CORP /DE/ | $812,105 | 31,295 | 0.28% | Shares |
| VANGUARD GROUP INC | $799,814 | 35,390 | 0.27% | Shares |
| UBS Group AG | $758,493 | 29,229 | 0.26% | Shares |
| FRED ALGER MANAGEMENT, LLC | $622,904 | 24,004 | 0.21% | Shares |
| XTX Topco Ltd | $436,687 | 16,828 | 0.15% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $422,907 | 16,297 | 0.14% | Shares |
| LMR Partners LLP | $351,804 | 13,557 | 0.12% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $321,105 | 12,374 | 0.11% | Shares |
| Alyeska Investment Group, L.P. | $264,379 | 10,188 | 0.09% | Shares |
| Fisher Asset Management, LLC | $255,348 | 9,840 | 0.09% | Shares |
| Nuveen, LLC | $253,791 | 9,780 | 0.09% | Shares |
| RHUMBLINE ADVISERS | $210,965 | 8,130 | 0.07% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $208,353 | 8,029 | 0.07% | Shares |
| WELLS FARGO & COMPANY/MN | $173,813 | 6,698 | 0.06% | Shares |
| MetLife Investment Management, LLC | $121,939 | 4,699 | 0.04% | Shares |
| Bank of New York Mellon Corp | $110,002 | 4,239 | 0.04% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $106,395 | 4,100 | 0.04% | Shares |
| China Universal Asset Management Co., Ltd. | $94,718 | 3,650 | 0.03% | Shares |
| MORGAN STANLEY | $94,458 | 3,640 | 0.03% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $87,737 | 3,381 | 0.03% | Shares |
| CITIGROUP INC | $78,654 | 3,031 | 0.03% | Shares |
| JPMORGAN CHASE & CO | $78,292 | 3,044 | 0.03% | Shares |
| Vanguard Global Advisers, LLC | $66,692 | 2,570 | 0.02% | Shares |
| Police & Firemen's Retirement System of New Jersey | $56,208 | 2,166 | 0.02% | Shares |
| BlackRock, Inc. | $53,976 | 2,080 | 0.02% | Shares |
| STRS OHIO | $36,330 | 1,400 | 0.01% | Shares |
| NORTHERN TRUST CORP | $29,817 | 1,149 | 0.01% | Shares |
| BARCLAYS PLC | $28,805 | 1,110 | 0.01% | Shares |
| Legal & General Group Plc | $18,554 | 715 | 0.01% | Shares |
| Ameritas Investment Partners, Inc. | $17,283 | 666 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $15,232 | 587 | 0.01% | Shares |
| Tower Research Capital LLC (TRC) | $11,107 | 428 | 0.00% | Shares |
| FMR LLC | $9,031 | 348 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $6,000 | 244 | 0.00% | Shares |
| State of Wyoming | $5,501 | 212 | 0.00% | Shares |
| DEUTSCHE BANK AG\ | $3,711 | 143 | 0.00% | Shares |
| Sterling Capital Management LLC | $675 | 26 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $564 | 21,715 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $39 | 1,508 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $26 | 1 | 0.00% | Shares |
Company insiders 19 insiders · 5 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Craig C Parker | Chief Executive Officer | May 1, 2026 M | 16,553 | 0 | 1 | $-150,785 |
| Andrew Pedrum Maleki | Chief Financial Officer | Nov. 12, 2025 A | — | 0 | 0 | $0 |
| Charles O Williams | Chief Operating Officer | May 1, 2026 M | 16,571 | 0 | 2 | $-98,976 |
| Yang Li | Exec. Vice President, Research | May 1, 2026 M | 17,216 | 0 | 2 | $-75,010 |
| Geertrui Vanhove | Chief Medical Officer | Aug. 12, 2021 A | — | 0 | 0 | $0 |
| Mace Rothenberg | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| Mary Haak-Frendscho | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| Anna Berkenblit | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| David J Woodhouse | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| Tim Kutzkey | Director | May 13, 2026 A | 1,016,658 | 18 | 0 | $5,984,632 |
| Christopher Y Chai | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| Eric Bjerkholt | Director | May 13, 2026 A | — | 0 | 0 | $0 |
| Mitchell J Blutt MD | Director | Nov. 23, 2020 A | 410,000 | 0 | 0 | $0 |
| Benny Soffer | — | Aug. 11, 2021 A | 1,885,000 | 0 | 0 | $0 |
| Kevin Harold Livingston | — | Aug. 11, 2021 A | 1,885,000 | 0 | 0 | $0 |
| Consonance Life Sciences | — | Aug. 11, 2021 A | 1,885,000 | 0 | 0 | $0 |
| Jennifer Jarrett | — | Aug. 11, 2021 D | 30,000 | 0 | 0 | $0 |
| Christopher Haqq | — | Aug. 11, 2021 D | 30,000 | 0 | 0 | $0 |
| Donald J Santel | — | Aug. 11, 2021 D | 30,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| The Column Group III GP, LP, The Column Group III, LP, The Column Group III-A, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson ×3 filings | May 18, 2026 | 29.30% | Amendment | — | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Consonance Life Sciences, LLC, Mitchell Blutt, Benny Soffer, Kevin Livingston ×2 filings | Sept. 29, 2021 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.04% | 24,670 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 42,455 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 7,916 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 67,290 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 174,956 SH | Aug. 8, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 102,939 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 282,365 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 655 SH | Aug. 8, 2026 | Daily |